Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. The lattice is an all-sp³, rigid three-dimensional network whose local connectivity echoes that of diamond, conferring exceptional chemical inertness, thermal robustness, and pronounced hydrophobicity. In structural hierarchy, diamantane is the higher homologue of adamantane, preserving the same symmetry logic while increasing framework complexity. Adamantane (C₁₀H₁₆) is a colorless crystalline solid with a camphor-like odor and is the prototypical diamondoid. Its defining feature is a strain-free, highly symmetrical tricyclic cage of saturated, tetrahedral carbons that restricts internal bond rotation relative to ordinary acyclic or monocyclic hydrocarbons. Adamantane occurs naturally in certain crude oils and is also readily accessible synthetically, making it a durable scaffold for structure–property studies and a useful building block in materials and molecular design. Synthetically, adamantane can be produced via the thermal, catalyst-assisted rearrangement of dicyclopentadiene (C₁₀H₁₆ → C₁₀H₁₆, Δ, catalyst), a classic cage-forming transformation that delivers a low-strain, high-symmetry framework from readily available feedstock. This blueprint underpins routes to higher diamondoids such as diamantane by extending the logic of cage construction from simpler polycyclic precursors. According to APO Research’s survey and statistical analysis, the global diamantane market was valued at US$442.21 thousand in 2023 and is projected to reach US$697.62 thousand by 2030, implying a 2024–2030 CAGR of 6.83%. The global adamantane market was valued at US$184.47 million in 2023 and is expected to reach US$262.53 million by 2030 (CAGR 4.97%). By production value, North America’s adamantane market rises from US$51.84 million (2023) to US$72.62 million (2030; 4.75%), while diamantane increases from US$217.62 thousand to US$354.61 thousand (7.49%). Europe’s adamantane advances from US$28.91 million to US$39.80 million (4.44%) and diamantane from US$51.38 thousand to US$76.60 thousand (5.27%). China’s adamantane expands from US$44.45 million to US$71.04 million (6.66%) and diamantane from US$70.22 thousand to US$114.88 thousand (7.51%). Japan’s adamantane grows from US$40.73 million to US$55.47 million (4.28%) and diamantane from US$99.85 thousand to US$147.20 thousand (5.79%). Overall, adamantane retains the larger revenue base with steady growth, while diamantane—though smaller in absolute terms—exhibits a faster compound growth trajectory over 2024–2030.
